Vanguard Capital Management’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$122M Buy
7,552,313
+1,241,344
+20% +$28.5M ﹤0.01% 1414
2026
Q2
$140M Sell
6,310,969
-94,100
-1% -$1.75M ﹤0.01% 1359
2026
Q1
$116M Buy
+6,405,069
New +$110M ﹤0.01% 1389

Other funds holding DYN

Vanguard Capital Management's DYN Position: Q3 2026 in Review

Vanguard Capital Management increased its Dyne Therapeutics (DYN) stake by 20% in Q3 2026, buying an estimated $28.5M and bringing the position to 7,552,313 shares worth $122M. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Vanguard Capital Management first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. The position peaked at $140M in Q2 2026. 268 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Vanguard Capital Management held 7,552,313 shares of Dyne Therapeutics worth $122M as of Q3 2026.
  • Vanguard Capital Management bought 1,241,344 Dyne Therapeutics shares in Q3 2026, an estimated $28.5M.
  • Dyne Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1414 holding.
  • Vanguard Capital Management first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Dyne Therapeutics position peaked at $140M in Q2 2026.
  • 268 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.